CAIN
@CAIN_Lab
Followers
3K
Following
41K
Media
688
Statuses
7K
Cognitive Ageing and Impairment Neurosciences Lab, part of @BBBRC_ @UniversitySA. Led by A/Prof Tobias Loetscher and Prof Hannah Keage. Views are our own.
Joined June 2016
🏆 Nominate now: 2026 PM's Prizes for Science – Australia's most prestigious science awards. 8 prizes spanning STEM innovation, Indigenous knowledge systems & teaching excellence. $50K or $250K + national recognition. Know a deserving scientist or educator?
0
1
2
Yet more evidence that haloperidol is not a sedative. RCT to ⬇️ agitation in palliative care #delirium 1⃣haloperidol 2⃣lorazepam 3⃣halop + loraz 4⃣placebo Haloperidol monotherapy was not more efficacious than placebo in reducing RASS. https://t.co/ceA2P4Oj6y
8
38
158
The VasCog-2-WSO criteria provide updated international guidelines for diagnosing vascular cognitive impairment and #dementia, incorporating recent biomarker advancements. https://t.co/2KLr8NTQgr
1
50
163
We reassessed the @TheLancet 14 dementia risk factors and added poverty, wealth shocks, income inequality, & HIV. This provides a larger estimation of preventable dementia & exposes gender inequities with larger burdens in women. Out in @eBioMedicine
https://t.co/jvS2eFsN89.
2
26
61
A privilege to represent the population health perspective, alongside Carol Brayne @CamPubHealth , in this new @TheLancet Series on Alzheimer's disease. Expertly led by @GiovanniFrisoni Alzheimer's disease outlook: controversies and future directions
thelancet.com
For the first time, reductions in cerebral β-amyloid pathology load and rate of cognitive and functional decline have been achieved in Alzheimer's disease, through pharmacological intervention in...
1
2
3
New paper in Imaging Neuroscience by Sian Virtue-Griffiths, Nigel C. Rogasch, et al: Task-related changes in aperiodic activity are related to visual working memory capacity independent of event-related potentials and alpha oscillations https://t.co/49vv4NUxaZ
0
6
9
The VasCog-2-WSO criteria provide updated international guidelines for diagnosing vascular cognitive impairment and #dementia, incorporating recent biomarker advancements. https://t.co/X0D2xZ8Zx8
1
52
141
Revised Diagnostic Criteria for Vascular Cognitive Impairment and Dementia
jamanetwork.com
This Delphi study aimed to reach international consensus on the diagnosis of cognitive impairment and dementia via a revision of the International Society for Vascular Behavioural and Cognitive...
1
25
68
Prehabilitation Program for Older Adults Undergoing Major Elective Surgery: Individualized physical therapy, nutritional counseling with protein supplementation, and guided meditation for 3–4 weeks before major surgery https://t.co/Q2TUmkRL4Z
agsjournals.onlinelibrary.wiley.com
This pilot study demonstrates the feasibility of a prehabilitation program consisting of individualized physical therapy, nutritional counseling with protein supplementation, and guided meditation...
0
2
3
Out of 800+ studies on blood-based biomarkers for Alzheimer's, not a single one measured actual changes in patient outcomes. https://t.co/u8FMgNDVTV
bmj.com
Willem van Gool and colleagues argue that moves to use blood biomarkers in clinical practice or population screening are inappropriate without evidence on outcomes important to patients and carers...
2
4
7
Team Leader: Technical Services position now open! Come work with us on EEG, PSG and VR research studies. The role will support psychology researchers at the new Adelaide University 🧠 https://t.co/x5XAuMOV0l
lnkd.in
This link will take you to a page that’s not on LinkedIn
0
1
0
Really pleased to be joining @PrashSanders, Adrian Elliot, @melissaemm1 et al. on The CRE for Atrial Fibrillation (AF) to Reduce Burden of Disease. Looking forward to improving the identification and treatment of mood and cognitive symptoms in AF. Hannah https://t.co/2PwxJIaBCR
0
2
5
A&D Call for Papers: Alzheimer's & Dementia Special Issue: Neuromodulatory Subcortical Systems in Alzheimer's Disease Highlight your work on neurodegenerative disease pathogenesis in the NSS #AlzResearch ⏰Updated Deadline: Nov. 30, 2025 https://t.co/GIBQ46HHLM
1
3
6
📣 SPECIAL ANNOUNCEMENT: Evidence Synthesis Symposium (26th November) and Risk of Bias Workshop (27th November) in person in Adelaide and Online Please come and join us for what should be a fantastic event! https://t.co/nQZzfNJDhD
0
6
13
New paper with @JanetJanbek using 🇩🇰 registry data to examine prevalence/co-occurrence of dementia risk factors. 82% of people >65 have multiple risk factors, speaking to the need for upstream public health action. More work soon from this collaboration! https://t.co/LvYHjkX1ZC
0
1
1
✨✨We are excited to announce the OHBM Australian Chapter 2025 Annual Meeting!🧠🇦🇺 📢Abstract submissions & registration now OPEN (submissions close September 15th 5pm) 📍Melbourne 🏙️☕ 📅Wednesday, November 12, 2025 https://t.co/He5jMHXdFb We hope to see you there! 🤩
0
8
15
Call For Papers! Alzheimer's & Dementia Special Issue: Neuromodulatory Subcortical Systems in Alzheimer's Disease Research on the intersection of the Neuromodulatory Subcortical Systems and AD are welcome! #AlzResearch ⏰Deadline: Aug. 30, 2025 https://t.co/GIBQ46HHLM
0
3
6
Does ideal #bloodpressure vary by cognitive domain? Nice study by colleague Matthew Lennon showing the relationship between BP and cognitive function is nonlinear. https://t.co/khfWgHhbJI
0
1
10
A new study led by @clem_cavailles has linked three distinct sleep profiles to dementia and cardiovascular disease (CVD) in older men. 📖 Learn more: DOI: 10.1038/s43856-025-01019-x
1
1
4